UCB S.A./ BE0003739530 /

6/8/2023 8:00:08 AM	Chg. -0.38	Volume	Bid7:43:10 PM	Ask7:43:10 PM	Market Capitalization	Dividend Y.	P/E Ratio
83.56EUR	-0.45%	0 Turnover: 0.00	-Bid Size: -	-Ask Size: -	16.19 bill.EUR	1.55%	38.94

GlobeNewswire 3/24/2022 Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage of its...

GlobeNewswire 3/23/2022 Lumos Pharma to Participate in the Cantor Rare Disease Symposium

GlobeNewswire 3/10/2022 Lumos Pharma Reports Full Year 2021 Financial Results and Announces Plan to Perform Interim Analyses...

GlobeNewswire 3/10/2022 Lumos Pharma to Participate in Upcoming Investor Conferences

GlobeNewswire 3/8/2022 BrightInsight and UCB Partner to Build Digital Care Solutions for Rare Diseases

GlobeNewswire 3/4/2022 Zogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) a...

GlobeNewswire 2/28/2022 Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results

GlobeNewswire 2/7/2022 Biogen and Xbrane Announce Commercialization and License Agreement for Proposed Biosimilar Referenci...

GlobeNewswire 1/31/2022 SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates APR, ZGNX, CRHC, DNAA

GlobeNewswire 1/25/2022 SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ZGNX, BFC, EXTN, SMFR; Shareholders are Enc...

GlobeNewswire 1/22/2022 Lifshitz Law Firm, P.C. Announces Investigation of ATVI, BFC, SMFR, and ZGNX

GlobeNewswire 1/21/2022 Moore Kuehn Encourages ATVI, ZGNX, DNAC, and VHAQ Investors to Contact Law Firm

GlobeNewswire 1/20/2022 FutureFuel Appoints Charles W. Lyon Senior Vice President of Strategy and Planning

GlobeNewswire 1/20/2022 Halper Sadeh LLP Investigates ZGNX, BFC, FLMN; Shareholders are Encouraged to Contact the Firm

GlobeNewswire 1/19/2022 ZOGENIX ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of ZGNX and Encourages Investors to C...

GlobeNewswire 1/19/2022 SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Zogenix, Inc. Merger

GlobeNewswire 1/19/2022 SHAREHOLDER UPDATE: Brodsky & Smith Reminds Investors of the Following Investigations: Zogenix, Inc....

GlobeNewswire 1/19/2022 ZGNX Alert: Monsey Firm of Wohl & Fruchter LLP Investigating Acquisition of Zogenix by UCB

GlobeNewswire 1/12/2022 IEEE-ISTO Announces a New Alliance to Advance Clinical Research Data Sharing

GlobeNewswire 1/5/2022 Lumos Pharma to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

GlobeNewswire 12/14/2021 HMNC Brain Health Names Nir Naor New Chief Financial Officer

GlobeNewswire 12/2/2021 Novartis R&D day spotlights attractive growth profile, underpinned by strong in-market brands, 20 po...

GlobeNewswire 11/10/2021 Lumos Pharma to Participate in Upcoming Investor Conferences

GlobeNewswire 11/9/2021 LAVA Therapeutics Expands Management Team with Three Key Appointments

GlobeNewswire 11/3/2021 Lumos Pharma Reports Third Quarter 2021 Financial Results and Provides Clinical Updates